BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 15505131)

  • 1. Early withdrawal of statin therapy in patients with non-ST-segment elevation myocardial infarction: national registry of myocardial infarction.
    Spencer FA; Fonarow GC; Frederick PD; Wright RS; Every N; Goldberg RJ; Gore JM; Dong W; Becker RC; French W;
    Arch Intern Med; 2004 Oct; 164(19):2162-8. PubMed ID: 15505131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of statin initiation, intensification, and maximization among patients hospitalized with an acute myocardial infarction.
    Arnold SV; Kosiborod M; Tang F; Zhao Z; Maddox TM; McCollam PL; Birt J; Spertus JA
    Circulation; 2014 Mar; 129(12):1303-9. PubMed ID: 24496318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of statin adherence and interruption within 6 months after ST-segment elevation myocardial infarction (STEMI): Results from the real-world regional registry FAST-STEMI.
    Giacobbe F; Giannino G; Annone U; Morena A; Di Vita U; Carmagnola L; Nebiolo M; Rollo C; Ravetti E; Troncone M; Pancotti C; De Filippo O; Bruno F; Angelini F; Gaido L; Fariselli P; D'Ascenzo F; Giammaria M; De Ferrari GM
    Int J Cardiol; 2024 Jun; 405():131933. PubMed ID: 38437950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns and predictors of intensive statin therapy among patients with diabetes mellitus after acute myocardial infarction.
    Abdallah MS; Kosiborod M; Tang F; Karrowni WY; Maddox TM; McGuire DK; Spertus JA; Arnold SV
    Am J Cardiol; 2014 Apr; 113(8):1267-72. PubMed ID: 24560324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statin withdrawal and treating COVID-19 patients.
    Fedson DS
    Pharmacol Res Perspect; 2021 Dec; 9(6):e00861. PubMed ID: 34708573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Five-year persistence of statins after acute myocardial infarction in statin-naïve patients].
    Simonyi G; Ferenci T; Finta E; Medvegy M
    Orv Hetil; 2024 Feb; 165(5):171-176. PubMed ID: 38310536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pragmatic evaluation of events and benefits of lipid lowering in older adults (PREVENTABLE): Trial design and rationale.
    Joseph J; Pajewski NM; Dolor RJ; Sellers MA; Perdue LH; Peeples SR; Henrie AM; Woolard N; Jones WS; Benziger CP; Orkaby AR; Mixon AS; VanWormer JJ; Shapiro MD; Kistler CE; Polonsky TS; Chatterjee R; Chamberlain AM; Forman DE; Knowlton KU; Gill TM; Newby LK; Hammill BG; Cicek MS; Williams NA; Decker JE; Ou J; Rubinstein J; Choudhary G; Gazmuri RJ; Schmader KE; Roumie CL; Vaughan CP; Effron MB; Cooper-DeHoff RM; Supiano MA; Shah RC; Whittle JC; Hernandez AF; Ambrosius WT; Williamson JD; Alexander KP;
    J Am Geriatr Soc; 2023 Jun; 71(6):1701-1713. PubMed ID: 37082807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two-Week Interruption of Statin Therapy Results in an Exaggerated Inflammatory Monocyte Phenotype in Young Patients With Myocardial Infarction Without Standard Modifiable Risk Factors.
    Mol JQ; van Tuijl J; Bekkering S; Rodwell L; Pop GAM; Netea MG; van Royen N; Riksen NP; El Messaoudi S
    J Am Heart Assoc; 2024 Apr; 13(8):e032978. PubMed ID: 38563381
    [No Abstract]   [Full Text] [Related]  

  • 9. Lipid Lowering After Myocardial Infarction: Too Little, Too Late.
    Montalescot G; Granger C; Procopi N
    J Am Coll Cardiol; 2023 Oct; 82(18):1748-1750. PubMed ID: 37879778
    [No Abstract]   [Full Text] [Related]  

  • 10. Myocardial Infarction Care Among The Elderly: Declining Treatment With Increasing Age In Two Countries.
    Hsu J; Iversen T; Price M; Moger TA; Tevis D; Hagen TP; Dow WH
    Health Aff (Millwood); 2021 Sep; 40(9):1483-1490. PubMed ID: 34495733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interrater reliability of a national acute myocardial infarction register.
    Govatsmark RE; Sneeggen S; Karlsaune H; Slørdahl SA; Bønaa KH
    Clin Epidemiol; 2016; 8():305-12. PubMed ID: 27574467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics and treatment of nonagenarian patients with vascular disease admitted to internal medicine services. NONAVASC-2 registry.
    Espiño-Álvarez A; Vargas-Tirado M; Royuela M; Gil-Díaz A; Fuente-Cosío S; Cornejo-Saucedo MÁ; Tejero-Delgado MA; Novo-Veleiro I; Bellver-Álvarez TM; Gullón A;
    Rev Clin Esp (Barc); 2023 Nov; 223(9):569-577. PubMed ID: 37717922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dexmedetomidine Withdrawal Mimicking ST-Elevation Myocardial Infarction.
    Lakra P; Rao SJ; Dangol RK; Saleh N
    CJC Open; 2023 Oct; 5(10):754-756. PubMed ID: 37876884
    [No Abstract]   [Full Text] [Related]  

  • 14. Lipid compartments and lipid metabolism as therapeutic targets against coronavirus.
    Cesar-Silva D; Pereira-Dutra FS; Giannini ALM; Maya-Monteiro CM; de Almeida CJG
    Front Immunol; 2023; 14():1268854. PubMed ID: 38106410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statins: Beneficial Effects in Treatment of COVID-19.
    Lashgari NA; Roudsari NM; Shamsnia H; Shayan M; Momtaz S; Abdolghaffari AH; Matbou Riahi M; Jamialahmadi T; Guest PC; Reiner Ž; Sahebkar A
    Adv Exp Med Biol; 2023; 1412():457-476. PubMed ID: 37378783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statins in High Cardiovascular Risk Patients: Do Comorbidities and Characteristics Matter?
    Rossini E; Biscetti F; Rando MM; Nardella E; Cecchini AL; Nicolazzi MA; Covino M; Gasbarrini A; Massetti M; Flex A
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholesterol-lowering drugs for high-risk hypercholesterolemia patients with COVID-19 while on Paxlovid™ therapy.
    Vuorio A; Kovanen PT; Raal F
    Future Virol; 2022 Jul; ():. PubMed ID: 35935448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intensity of and Adherence to Lipid-Lowering Therapy as Predictors of Major Adverse Cardiovascular Outcomes in Patients With Coronary Heart Disease.
    Mazhar F; Hjemdahl P; Clase CM; Johnell K; Jernberg T; Sjölander A; Carrero JJ
    J Am Heart Assoc; 2022 Jul; 11(14):e025813. PubMed ID: 35861825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral Drugs Against COVID-19.
    Mikus G; Foerster KI; Terstegen T; Vogt C; Said A; Schulz M; Haefeli WE
    Dtsch Arztebl Int; 2022 Apr; 119(15):263-269. PubMed ID: 35302484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association Between Statin Use and Daptomycin-related Musculoskeletal Adverse Events: A Mixed Approach Combining a Meta-analysis and a Disproportionality Analysis.
    Chuma M; Nakamoto A; Bando T; Niimura T; Kondo Y; Hamano H; Okada N; Asada M; Zamami Y; Takechi K; Goda M; Miyata K; Yagi K; Yoshioka T; Izawa-Ishizawa Y; Yanagawa H; Tasaki Y; Ishizawa K
    Clin Infect Dis; 2022 Oct; 75(8):1416-1422. PubMed ID: 35262686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.